[18F]AlF-NOTA-FAPI-04

N/A

Report date: 2025/10/20 14:27:29

Base Information

Drug Name[18F]AlF-NOTA-FAPI-04
Drug Alias Name18F-AlF-NOTA-FAPI-04\[18F\]AIF-NOTA-FAPI-04
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesSichuan Provincial People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Provincial People'S Hospital
Inactive CompaniesN/A
Active IndicationsKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A